New Drug Shows Promise for Hard-to-Treat Breast Cancer

A drug already in trials for blood cancer could transform treatment for lobular breast cancer, a difficult-to-detect form affecting 15% of breast cancer patients.

Scientists found the drug slowed tumor growth and spread in mice with minimal side effects.